Biochemistry Reference Ranges: Difference between revisions

From Te Matau a Māui | Laboratory Services
Jump to navigation Jump to search
(Created page with "Page under construction Please try again later.")
 
mNo edit summary
 
(58 intermediate revisions by the same user not shown)
Line 1: Line 1:
Page under construction
{| class="wikitable"
|'''TEST'''
|'''SEX/AGE'''
|'''REFERENCE RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''AFP'''
|
|'''0-16'''
|'''ug/L'''
|
|-
|'''Albumin'''
|'''0-14 days'''
|'''28-41'''
|'''g/L'''
|
|-
|
|'''>14 days - 1 yr'''
|'''28-45'''
|'''g/L'''
|
|-
|
|'''>1-8 yrs'''
|'''35-45'''
|'''g/L'''
|
|-
|
|'''>8-15 yrs'''
|'''37-47'''
|'''g/L'''
|
|-
|
|'''>15 yrs'''
|'''32-48'''
|'''g/L'''
|
|-
|'''ALP'''
|'''0-1 yr'''
|'''60-500'''
|'''U/L'''
|
|-
|
|'''1-10 yrs'''
|'''80-360'''
|'''U/L'''
|
|-
|
|'''11-16 yrs (male)'''
|'''90-450'''
|'''U/L'''
|
|-
|
|'''11-16 yrs (female)'''
|'''80-400'''
|'''U/L'''
|
|-
|
|'''>16-18 yrs (male)'''
|'''60-300'''
|'''U/L'''
|
|-
|
|'''>18 yrs'''
|'''30-150'''
|'''U/L'''
|
|-
|'''ALT'''
|'''male'''
|'''0-40'''
|'''U/L'''
|
|-
|
|'''female'''
|'''0-30'''
|'''U/L'''
|
|-
|'''Ammonia'''
|'''0-30 days'''
|'''<50'''
|'''umol/L'''
|
|-
|
|'''>30 days - Adult'''
|'''11-32'''
|'''umol/L'''
|
|-
|'''AST'''
|'''<1 month'''
|'''20-200'''
|'''U/L'''
|
|-
|
|'''1 month-2 yrs'''
|'''20-80'''
|'''U/L'''
|
|-
|
|'''>2-5 yrs'''
|'''15-60'''
|'''U/L'''
|
|-
|
|'''>5 yrs'''
|'''10-50'''
|'''U/L'''
|
|-
|'''bHCG'''
|'''non-pregnant adult'''
|'''<5'''
|'''IU/L'''
|
|-
|'''B12'''
|
|'''130-650'''
|'''pmol/L'''
|
|-
|
|'''grey-zone'''
|'''130-250'''
|'''pmol/L'''
|
|-
|'''Bicarbonate (HCO3)'''
|
|'''22-32'''
|'''mmol/L'''
|
|-
|'''Bilirubin (Direct/Conjugated)'''
|
|'''0-5'''
|'''umol/L'''
|
|-
|'''Bilirubin (Total)'''
|'''<24 hrs (cord blood)'''
|'''<50'''
|'''umol/L'''
|
|-
|
|'''24 hrs (day after birth)'''
|'''<100'''
|'''umol/L'''
|
|-
|
|'''48 hrs (2 days after birth)'''
|'''<140'''
|'''umol/L'''
|
|-
|
|'''3 days'''
|'''<200'''
|'''umol/L'''
|
|-
|
|'''4-14 days'''
|'''<170'''
|'''umol/L'''
|
|-
|
|'''2-6 weeks'''
|'''3-23'''
|'''umol/L'''
|
|-
|
|'''>6 weeks'''
|'''2-20'''
|'''umol/L'''
|
|-
|'''BNP (NT-proBNP)'''
|'''0-50 yrs'''
|'''<52'''
|'''pmol/L'''
|
|-
|
|'''>50-75 yrs'''
|'''<105'''
|'''pmol/L'''
|
|-
|
|'''>75 yrs'''
|'''<211'''
|'''pmol/L'''
|
|-
|'''CA 125'''
|
|'''0-35'''
|'''kIU/L'''
|
|-
|'''CA 153'''
|
|'''<30'''
|'''kIU/L'''
|
|-
|'''CA 199'''
|
|'''<37'''
|'''kIU/L'''
|
|-
|'''Calcium'''
|
|'''2.2-2.6'''
|'''mmol/L'''
|
|-
|'''CEA'''
|
|'''0-5'''
|'''ug/L'''
|
|-
|'''Chloride'''
|
|'''95-110'''
|'''mmol/L'''
|
|-
|'''CK'''
|'''male'''
|'''60-220'''
|'''U/L'''
|
|-
|
|'''female'''
|'''30-180'''
|'''U/L'''
|
|-
|'''Cortisol'''
|'''random'''
|'''170-540'''
|'''nmol/L'''
|'''0800 diurnal peak'''
|-
|
|'''Short Synacthen Test'''
|'''>400 (normal)'''
|'''nmol/L'''
|'''30min post'''
|-
|
|'''Dexamethasone Suppression Test'''
|'''<50 (excludes Cushing's)'''
|'''nmol/L'''
|'''0800 post dose at 2400hrs'''
|-
|
|'''Dexamethasone Suppression Test'''
|'''<50 (excludes Cushing's)'''
|'''nmol/L'''
|'''0800 post dose at 2400hrs'''
|-
|'''Creatinine'''
|'''<30 days
|'''20-60'''
|'''umol/L'''
|
|-
|
|'''>1 month - 2 yrs'''
|'''20-50'''
|'''umol/L'''
|
|-
|
|'''>2-4 yrs'''
|'''20-60'''
|'''umol/L'''
|
|-
|
|'''>4-6 yrs'''
|'''25-65'''
|'''umol/L'''
|
|-
|
|'''>6-10 yrs'''
|'''25-70'''
|'''umol/L'''
|
|-
|
|'''>10-15 yrs'''
|'''40-80'''
|'''umol/L'''
|
|-
|
|'''>15 yrs (male)'''
|'''50-110'''
|'''umol/L'''
|
|-
|
|'''>15 yrs (female)'''
|'''45-90'''
|'''umol/L'''
|
|-
|'''CRP'''
|
|'''<5'''
|'''mg/L'''
|
|-
|'''eGFR'''
|
|'''80-120'''
|'''mL/min/1.73m2'''
|'''GFR declines by 1mL/min/year over age 40 years'''
|-
|'''Ferritin
|'''<15 yrs'''
|'''15-150'''
|'''ug/L'''
|
|-
|
|'''>15-30 yrs (male)'''
|'''20-350'''
|'''ug/L'''
|
|-
|
|'''>15-50 yrs (female)'''
|'''20-200'''
|'''ug/L'''
|
|-
|
|'''>30 yrs (male)'''
|'''20-500'''
|'''ug/L'''
|
|-
|
|'''>50 yrs (female)'''
|'''20-350'''
|'''ug/L'''
|
|-
|'''Folate'''
|
|'''>8'''
|'''nmol/L'''
|
|-
|'''FSH'''
|'''<10 yrs'''
|'''0-6.5'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''0-6.5 (pre-pubertal)'''
|'''IU/L'''
|'''levels rise during puberty towards adult range'''
|-
|
|'''>15 yrs (female)'''
|
|
|
|-
|
|'''Follicular'''
|'''3-10'''
|'''IU/L'''
|
|-
|
|'''Mid-Cycle'''
|'''4-25'''
|'''IU/L'''
|
|-
|
|'''Luteal'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Post-Menopausal'''
|'''>20'''
|'''IU/L'''
|
|-
|
|'''Antenatal'''
|'''<1'''
|'''IU/L'''
|
|-
|
|'''Male'''
|'''2-12'''
|'''IU/L'''
|
|-
|'''GGT'''
|'''<6 months'''
|'''<150'''
|'''U/L'''
|
|-
|
|'''>6-12 months'''
|'''<50'''
|'''U/L'''
|
|-
|
|'''>1-12 yrs'''
|'''<30'''
|'''U/L'''
|
|-
|
|'''>12 yrs (male)'''
|'''10-50'''
|'''U/L'''
|
|-
|
|'''>12 yrs (female)'''
|'''10-35'''
|'''U/L'''
|
|-
|'''Glucose'''
|'''Random'''
|'''3.5-7.7'''
|'''mmol/L'''
|
|-
|
|'''Fasting'''
|'''3.5-6.0'''
|'''mmol/L'''
|
|-
|
|'''Polycose test'''
|'''<7.8'''
|'''mmol/L'''
|'''1hr post'''
|-
|'''HbA1c'''
|'''Non-diabetic'''
|'''20-40'''
|'''mmol/mol'''
|
|-
|
|'''Pre-diabetes'''
|'''41-49'''
|'''mmol/mol'''
|
|-
|
|'''Diabetes'''
|'''>49'''
|'''mmol/mol'''
|
|-
|'''IgA'''
|'''<1 yr'''
|'''0.0-0.3'''
|'''g/L'''
|
|-
|
|'''1-<3 yrs'''
|'''0.0-0.9'''
|'''g/L'''
|
|-
|
|'''3-<6 yrs'''
|'''0.3-1.5'''
|'''g/L'''
|
|-
|
|'''6-<14 yrs'''
|'''0.5-2.2'''
|'''g/L'''
|
|-
|
|'''14-<19 yrs'''
|'''0.5-2.9'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''0.4-2.3'''
|'''g/L'''
|
|-
|'''IgG'''
|'''<15 days'''
|'''3.2-14.0'''
|'''g/L'''
|
|-
|
|'''15 days - <1 yr'''
|'''2.0-7.0'''
|'''g/L'''
|
|-
|
|'''1-<4 yrs'''
|'''3.2-11.5'''
|'''g/L'''
|
|-
|
|'''4-<10 yrs'''
|'''5.4-13.6'''
|'''g/L'''
|
|-
|
|'''10-<19 yrs'''
|'''6.6-15.3'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''7.0-16.0'''
|'''g/L'''
|
|-
|'''IgM'''
|'''<15 days'''
|'''0.1-0.4'''
|'''g/L'''
|
|-
|
|'''15 days - <13 wks'''
|'''0.1-0.7'''
|'''g/L'''
|
|-
|
|'''1-<4 yrs'''
|'''3.2-11.5'''
|'''g/L'''
|
|-
|
|'''13 wks - <1 yr'''
|'''0.2-0.9'''
|'''g/L'''
|
|-
|
|'''1-<19 yrs'''
|'''0.4-1.9'''
|'''g/L'''
|
|-
|
|'''Adult'''
|'''0.4-2.3'''
|'''g/L'''
|
|-
|'''Iron'''
|'''<2 months'''
|'''10-31'''
|'''umol/L'''
|
|-
|
|'''2 months - 1 yr'''
|'''4-27'''
|'''umol/L'''
|
|-
|
|'''>1-10 yrs'''
|'''5-23'''
|'''umol/L'''
|
|-
|
|'''>10-18 yrs'''
|'''8-32'''
|'''umol/L'''
|
|-
|
|'''>18 yrs'''
|'''10-30'''
|'''umol/L'''
|
|-
|'''LDH'''
|'''<14 days'''
|'''310-1220'''
|'''IU/L'''
|
|-
|
|'''>14 days - 1 yr'''
|'''190-450'''
|'''IU/L'''
|
|-
|
|'''>1-10 yrs'''
|'''190-320'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''160-280'''
|'''IU/L'''
|
|-
|
|'''>15-18 yrs'''
|'''130-250'''
|'''IU/L'''
|
|-
|
|'''>18 yrs'''
|'''110-220'''
|'''IU/L'''
|
|-
|'''LH'''
|'''<10 yrs'''
|'''0-2.5'''
|'''IU/L'''
|
|-
|
|'''>10-15 yrs'''
|'''0-2.5'''
|'''IU/L'''
|'''levels rise during puberty towards adult range'''
|-
|
|'''>15 (female)'''
|
|
|
|-
|
|'''Follicular'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Mid-Cycle'''
|'''10-75'''
|'''IU/L'''
|
|-
|
|'''Luteal'''
|'''2-8'''
|'''IU/L'''
|
|-
|
|'''Post-Menopausal'''
|'''>15'''
|'''IU/L'''
|
|-
|
|'''Antenatal'''
|'''<1'''
|'''IU/L'''
|
|-
|
|'''Male'''
|'''2-9'''
|'''IU/L'''
|
|-
|'''Lipase'''
|
|'''10-70'''
|'''U/L'''
|
|-
|'''Magnesium
|
|'''0.6-1.2'''
|'''mmol/L'''
|
|-
|'''Oestradiol'''
|'''Follicular'''
|'''77-920'''
|'''pmol/L'''
|
|-
|
|'''Mid-Cycle'''
|'''140-2380'''
|'''pmol/L'''
|
|-
|
|'''Luteal'''
|'''77-1145'''
|'''pmol/L'''
|
|-
|
|'''Post-Menopausal'''
|'''<103'''
|'''pmol/L'''
|
|-
|
|'''Male'''
|'''<160'''
|'''pmol/L'''
|
|-
|'''Osmolality'''
|
|'''280-300'''
|'''mosm/kg'''
|
|-
|'''Phosphate'''
|'''<30 days'''
|'''1.3-2.5'''
|'''mmol/L'''
|
|-
|
|'''30 days - 1 yr'''
|'''1.2-2.2'''
|'''mmol/L'''
|
|-
|
|'''>1-4 yrs'''
|'''1.1-2.0'''
|'''mmol/L'''
|
|-
|
|'''>4-11 yrs'''
|'''1.0-2.0'''
|'''mmol/L'''
|
|-
|
|'''>11-16 yrs'''
|'''0.9-1.9'''
|'''mmol/L'''
|
|-
|
|'''>16 yrs'''
|'''0.8-1.5'''
|'''mmol/L'''
|
|-
|'''Potassium
|
|'''3.5-5.2'''
|'''mmol/L'''
|
|-
|'''Progesterone'''
|'''Follicular'''
|'''1-4'''
|'''nmol/L'''
|
|-
|
|'''Luteal'''
|'''15-100'''
|'''nmol/L'''
|
|-
|
|'''Post-Menopausal'''
|'''<4'''
|'''nmol/L'''
|
|-
|
|'''Male'''
|'''0-1'''
|'''nmol/L'''
|
|-
|'''Prolactin'''
|'''Female'''
|'''25-630'''
|'''mIU/L'''
|
|-
|
|'''Male'''
|'''55-380'''
|'''mIU/L'''
|
|-
|'''Protein (Total)'''
|'''<2 months'''
|'''45/70'''
|'''g/L'''
|
|-
|
|'''>2-12 months'''
|'''50-80'''
|'''g/L'''
|
|-
|
|'''>1-6 yrs'''
|'''55/80'''
|'''g/L'''
|
|-
|
|'''>6-11 yrs'''
|'''60-83'''
|'''g/L'''
|
|-
|
|'''>11 yrs'''
|'''64-83'''
|'''g/L'''
|
|-
|'''PSA'''
|
|'''<4.0'''
|'''ug/L'''
|
|-
|'''PTH (Intact)'''
|
|'''1.6-7.2'''
|'''pmol/L'''
|
|-
|'''Rheumatoid Factor'''
|
|'''<30'''
|'''IU/L'''
|
|-
|'''Sodium'''
|
|'''135-145'''
|'''mmol/L'''
|
|-
|'''Transferrin'''
|'''<2 months'''
|'''1.3-2.3'''
|'''g/L'''
|
|-
|
|'''>2 months - 3 yrs'''
|'''1.6-3.3'''
|'''g/L'''
|
|-
|
|'''>3 yrs'''
|'''2.0-3.5'''
|'''g/L'''
|
|-
|'''% Saturation'''
|'''Male'''
|'''20-60'''
|'''%'''
|
|-
|
|'''Female'''
|'''20-50'''
|'''%'''
|
|-
|'''hs-Troponin I'''
|'''Male'''
|'''0-34'''
|'''ng/L'''
|
|-
|
|'''Female'''
|'''0-16'''
|'''ng/L'''
|
|-
|'''TSH'''
|'''<4 days'''
|'''1.0-20.0'''
|'''mIU/L'''
|
|-
|
|'''4 days - 1 month'''
|'''0.7-16.0'''
|'''mIU/L'''
|
|-
|
|'''>1-6 months'''
|'''0.5-6.0'''
|'''mIU/L'''
|
|-
|
|'''>6 months'''
|'''0.4-4.0'''
|'''mIU/L'''
|
|-
|'''Free T4'''
|'''4 days - <1 month'''
|'''10-40'''
|'''pmol/L'''
|
|-
|
|'''1 month - <1 yr'''
|'''10-30'''
|'''pmol/L'''
|
|-
|
|'''1-<12 yrs'''
|'''11-22'''
|'''pmol/L'''
|
|-
|
|'''12 yrs and above'''
|'''12-22'''
|'''pmol/L'''
|
|-
|'''Free T3'''
|'''<12 months'''
|'''4.5-10.5'''
|'''pmol/L'''
|
|-
|
|'''1-12 yrs'''
|'''3.8-8.6'''
|'''pmol/L'''
|
|-
|
|'''>12-18 yrs'''
|'''3.7-7.7'''
|'''pmol/L'''
|
|-
|
|'''>18 yrs'''
|'''2.5-6.0'''
|'''pmol/L'''
|
|-
|'''Urea'''
|'''<1 month'''
|'''1.1-6.1'''
|'''mmol/L'''
|
|-
|
|'''>1 month - 2 yrs'''
|'''0.7-5.0'''
|'''mmol/L'''
|
|-
|
|'''>2-4 yrs'''
|'''1.1-5.0'''
|'''mmol/L'''
|
|-
|
|'''>4-6 yrs'''
|'''1.1-5.7'''
|'''mmol/L'''
|
|-
|
|'''>6-10 yrs'''
|'''1.4-5.7'''
|'''mmol/L'''
|
|-
|
|'''>10-13 yrs'''
|'''1.8-6.4'''
|'''mmol/L'''
|
|-
|
|'''>13 yrs'''
|'''3.2-7.7'''
|'''mmol/L'''
|
|-
|'''Uric Acid'''
|'''0-12 yrs'''
|'''0.08-0.34'''
|'''mmol/L'''
|
|-
|
|'''>12 yrs (male)'''
|'''0.20-0.42'''
|'''mmol/L'''
|
|-
|
|'''>12 yrs (female)'''
|'''0.15-0.36'''
|'''mmol/L'''
|
|}




Please try again later.
{| class="wikitable"
|'''BLODD GASES'''
|'''ARTERIAL'''
|'''VENOUS'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''pH'''
|'''7.35-7.45'''
|'''7.30-7.40'''
|
|
|-
|'''pCO2'''
|'''35-45'''
|'''40-50'''
|'''mmHg'''
|
|-
|'''pO2'''
|'''75-105'''
|
|'''mmHg'''
|
|-
|'''Bicarbonate (HCO3)'''
|'''22-28'''
|'''22-32'''
|'''mmol/L'''
|
|-
|'''Standard Bicarbonate'''
|'''22-28'''
|'''22-32'''
|'''mmol/L'''
|
|-
|'''Base Excess (ABE)'''
|'''+/- 3'''
|'''+/- 3'''
|'''mmol/L'''
|
|-
|'''o2 Saturation'''
|'''97-100'''
|
|'''%'''
|
|-
|'''Carboxyhaemoglobin (COHb)'''
|'''0-1.5 (non-smoker)'''
|'''0-1.5 (non-smoker)'''
|'''%'''
|
|-
|
|'''<9 (smoker)'''
|'''<9 (smoker)'''
|'''%'''
|
|-
|'''MetHb'''
|'''0-1.5'''
|'''0-1.5'''
|'''%'''
|
|-
|'''Sodium'''
|'''135-145'''
|'''135-145'''
|'''mmol/L'''
|
|-
|'''Potassium'''
|'''3.5-5.2'''
|'''3.5-5.2'''
|'''mmol/L'''
|
|-
|'''Ionised Calcium'''
|'''1.15-1.30'''
|'''1.15-1.30'''
|'''mmol/L'''
|
|-
|'''Ionised Calcium - corrected (pH 7.4)'''
|'''1.13-1.26'''
|'''1.13-1.26'''
|'''mmol/L'''
|
|-
|'''Chloride'''
|'''95-110'''
|'''95-110'''
|'''mmol/L'''
|
|-
|'''Glucose (random)'''
|'''3.5-7.7'''
|'''3.5-7.7'''
|'''mmol/L'''
|
|-
|'''Lactate'''
|'''<2.0'''
|'''<2.0'''
|'''mmol/L'''
|
|-
|'''Anion Gap'''
|'''10-20'''
|'''10-20'''
|'''mmol/L'''
|
|-
|
|
|
|
|
|-
|'''CORD GASES'''
|'''ARTERIAL'''
|'''VENOUS'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''pH'''
|'''7.10-7.40'''
|'''7.22-7.44'''
|
|
|-
|'''pCO2'''
|'''42-74'''
|'''28-53'''
|'''mmHg'''
|
|-
|'''pO2'''
|'''6-28'''
|'''16-40'''
|'''mmHg'''
|
|-
|'''HCO3'''
|'''18-28'''
|'''17-26'''
|'''mmol/L'''
|
|-
|'''Base Excess'''
|'''-12 to +2'''
|'''-12 to +2'''
|'''mmol/L'''
|
|-
|'''Lactate'''
|'''<6.1'''
|'''<6.1'''
|'''mmol/L'''
|
|}
 
 
{| class="wikitable"
|'''Urine'''
|'''SEX/AGE'''
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''U Calcium (24hrs)'''
|
|'''2.5-7.5'''
|'''mmol/24hrs'''
|
|-
|'''U Creatinine (24hrs)'''
|'''0-6 months'''
|'''0.2-1.6'''
|'''mmol/24hrs'''
|
|-
|
|'''>6 months - 2 yrs'''
|'''0.2-2.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>2-6 yrs'''
|'''0.5-6.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>6-10 yrs'''
|'''1.5-12.6'''
|'''mmol/24hrs'''
|
|-
|
|'''>10-15 yrs'''
|'''2.0-20.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>15 yrs (male)'''
|'''9.0-18.0'''
|'''mmol/24hrs'''
|
|-
|
|'''>15 yrs (female)'''
|'''7.0-12.5'''
|'''mmol/24hrs'''
|
|-
|'''Creatinine Clearance'''
|
|'''>1.5'''
|'''ml/sec'''
|
|-
|'''U Albumin
|
|'''<30'''
|'''mg/L'''
|
|-
|'''U Alb/Crn Ratio'''
|'''Male'''
|'''<2.5'''
|'''g(alb)/mol(Crn)'''
|
|-
|
|'''Female'''
|'''<3.5'''
|'''g(alb)/mol(Crn)'''
|
|-
|'''U Osmolality'''
|'''0-6 yrs'''
|'''50-1200'''
|'''mosm/kg'''
|
|-
|
|'''>6 yrs'''
|'''300-1200'''
|'''mosm/kg'''
|
|-
|'''U pH'''
|
|'''5-8.8'''
|
|
|-
|'''U Phosphate (24hrs)'''
|
|'''16-48'''
|'''mmol/24hrs'''
|'''dependent on diet, age, muscle mass'''
|-
|'''U Potassium (24hrs)'''
|
|'''35-100'''
|'''mmol/24hrs'''
|'''diet dependent'''
|-
|'''U Protein (24hrs)'''
|
|'''0.0-0.14'''
|'''g/24hrs'''
|
|-
|'''U Pro/Crn Ratio'''
|
|'''<22.7'''
|'''g/mol'''
|
|-
|'''U Sodium (24hrs)'''
|
|'''100-250'''
|'''mmol/24hrs'''
|'''diet dependent'''
|-
|'''U Urea (24hrs)'''
|
|'''165-580'''
|'''mmol/24hrs'''
|
|}
 
 
{| class="wikitable"
|'''LIPIDS'''
|'''SEX/AGE'''
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''Cholesterol (Total)'''
|
|'''<4.0'''
|'''mmol/L'''
|
|-
|'''HDL Cholesterol'''
|
|'''>1.0'''
|'''mmol/L'''
|
|-
|'''LDL (calculated)'''
|
|'''<2.5'''
|'''mmol/L'''
|
|-
|'''Chol/HDL Ratio'''
|
|'''<4.5'''
|
|
|-
|'''Triglyceride'''
|
|'''<1.7'''
|'''mmol/L'''
|
|}
'''Optimal lipid levels are suggested by the New Zealand Guidelines Group.'''
'''http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012'''
 
 
{| class="wikitable"
|'''DRUGS'''
|
|'''REF RANGE'''
|'''UNITS'''
|'''COMMENTS'''
|-
|'''Carbamazepine'''
|'''Therapeutic range'''
|'''16-50'''
|'''umol/L'''
|
|-
|'''Digoxin'''
|'''Therapeutic range'''
|'''0.6-2.0'''
|'''nmol/L'''
|'''>6 hrs post-dose'''
|-
|'''Ethanol'''
|'''Nil detected'''
|'''<2.2'''
|'''mmol/L'''
|
|-
|'''Lithium'''
|'''for prophylaxis'''
|'''0.4-0.8'''
|'''mmol/L'''
|
|-
|
|'''for acute mania'''
|'''0.8-1.2'''
|'''mmol/L'''
|
|-
|
|'''toxicity is common'''
|'''>1.2'''
|'''mmol/L'''
|'''>12 hrs post-dose'''
|-
|'''Phenytoin'''
|'''Therapeutic range'''
|'''40-80'''
|'''umol/L'''
|
|-
|'''Salicylate'''
|'''Therapeutic range'''
|'''1.5-1.8'''
|'''mmol/L'''
|
|-
|
|'''Toxic'''
|'''>3.6'''
|'''mmol/L'''
|
|-
|'''Theophylline'''
|'''Therapeutic range'''
|'''55-110'''
|'''umol/L'''
|
|-
|'''Valproate'''
|'''<6 months'''
|'''28-55'''
|'''umol/L'''
|
|-
|
|'''>6 months'''
|'''350-700'''
|'''umol/L'''
|'''not reported but widely accepted as a trough range'''
|}
'''Note: Antibiotics - Gentamicin, Vancomycin and Tobramycin ranges, please refer to Pharmacy for dose and time related reference ranges.'''
 
 
'''Reference ranges have been set in agreeance with:'''
'''- The South Island Quality Assurance Group (SIQAG)'''
'''- Chemical Pathology Network New Zealand (CHEMPNNZ)'''
'''- Te Whatu Ora Hawkes Bay Chemical Pathologist'''
'''- Abbott Alinity assay specific reference ranges'''
''' - The LabNet Delphic Partners'''
 
 
'''Reference ranges reviewed August 2023'''

Latest revision as of 01:50, 12 September 2023

TEST SEX/AGE REFERENCE RANGE UNITS COMMENTS
AFP 0-16 ug/L
Albumin 0-14 days 28-41 g/L
>14 days - 1 yr 28-45 g/L
>1-8 yrs 35-45 g/L
>8-15 yrs 37-47 g/L
>15 yrs 32-48 g/L
ALP 0-1 yr 60-500 U/L
1-10 yrs 80-360 U/L
11-16 yrs (male) 90-450 U/L
11-16 yrs (female) 80-400 U/L
>16-18 yrs (male) 60-300 U/L
>18 yrs 30-150 U/L
ALT male 0-40 U/L
female 0-30 U/L
Ammonia 0-30 days <50 umol/L
>30 days - Adult 11-32 umol/L
AST <1 month 20-200 U/L
1 month-2 yrs 20-80 U/L
>2-5 yrs 15-60 U/L
>5 yrs 10-50 U/L
bHCG non-pregnant adult <5 IU/L
B12 130-650 pmol/L
grey-zone 130-250 pmol/L
Bicarbonate (HCO3) 22-32 mmol/L
Bilirubin (Direct/Conjugated) 0-5 umol/L
Bilirubin (Total) <24 hrs (cord blood) <50 umol/L
24 hrs (day after birth) <100 umol/L
48 hrs (2 days after birth) <140 umol/L
3 days <200 umol/L
4-14 days <170 umol/L
2-6 weeks 3-23 umol/L
>6 weeks 2-20 umol/L
BNP (NT-proBNP) 0-50 yrs <52 pmol/L
>50-75 yrs <105 pmol/L
>75 yrs <211 pmol/L
CA 125 0-35 kIU/L
CA 153 <30 kIU/L
CA 199 <37 kIU/L
Calcium 2.2-2.6 mmol/L
CEA 0-5 ug/L
Chloride 95-110 mmol/L
CK male 60-220 U/L
female 30-180 U/L
Cortisol random 170-540 nmol/L 0800 diurnal peak
Short Synacthen Test >400 (normal) nmol/L 30min post
Dexamethasone Suppression Test <50 (excludes Cushing's) nmol/L 0800 post dose at 2400hrs
Dexamethasone Suppression Test <50 (excludes Cushing's) nmol/L 0800 post dose at 2400hrs
Creatinine <30 days 20-60 umol/L
>1 month - 2 yrs 20-50 umol/L
>2-4 yrs 20-60 umol/L
>4-6 yrs 25-65 umol/L
>6-10 yrs 25-70 umol/L
>10-15 yrs 40-80 umol/L
>15 yrs (male) 50-110 umol/L
>15 yrs (female) 45-90 umol/L
CRP <5 mg/L
eGFR 80-120 mL/min/1.73m2 GFR declines by 1mL/min/year over age 40 years
Ferritin <15 yrs 15-150 ug/L
>15-30 yrs (male) 20-350 ug/L
>15-50 yrs (female) 20-200 ug/L
>30 yrs (male) 20-500 ug/L
>50 yrs (female) 20-350 ug/L
Folate >8 nmol/L
FSH <10 yrs 0-6.5 IU/L
>10-15 yrs 0-6.5 (pre-pubertal) IU/L levels rise during puberty towards adult range
>15 yrs (female)
Follicular 3-10 IU/L
Mid-Cycle 4-25 IU/L
Luteal 2-8 IU/L
Post-Menopausal >20 IU/L
Antenatal <1 IU/L
Male 2-12 IU/L
GGT <6 months <150 U/L
>6-12 months <50 U/L
>1-12 yrs <30 U/L
>12 yrs (male) 10-50 U/L
>12 yrs (female) 10-35 U/L
Glucose Random 3.5-7.7 mmol/L
Fasting 3.5-6.0 mmol/L
Polycose test <7.8 mmol/L 1hr post
HbA1c Non-diabetic 20-40 mmol/mol
Pre-diabetes 41-49 mmol/mol
Diabetes >49 mmol/mol
IgA <1 yr 0.0-0.3 g/L
1-<3 yrs 0.0-0.9 g/L
3-<6 yrs 0.3-1.5 g/L
6-<14 yrs 0.5-2.2 g/L
14-<19 yrs 0.5-2.9 g/L
Adult 0.4-2.3 g/L
IgG <15 days 3.2-14.0 g/L
15 days - <1 yr 2.0-7.0 g/L
1-<4 yrs 3.2-11.5 g/L
4-<10 yrs 5.4-13.6 g/L
10-<19 yrs 6.6-15.3 g/L
Adult 7.0-16.0 g/L
IgM <15 days 0.1-0.4 g/L
15 days - <13 wks 0.1-0.7 g/L
1-<4 yrs 3.2-11.5 g/L
13 wks - <1 yr 0.2-0.9 g/L
1-<19 yrs 0.4-1.9 g/L
Adult 0.4-2.3 g/L
Iron <2 months 10-31 umol/L
2 months - 1 yr 4-27 umol/L
>1-10 yrs 5-23 umol/L
>10-18 yrs 8-32 umol/L
>18 yrs 10-30 umol/L
LDH <14 days 310-1220 IU/L
>14 days - 1 yr 190-450 IU/L
>1-10 yrs 190-320 IU/L
>10-15 yrs 160-280 IU/L
>15-18 yrs 130-250 IU/L
>18 yrs 110-220 IU/L
LH <10 yrs 0-2.5 IU/L
>10-15 yrs 0-2.5 IU/L levels rise during puberty towards adult range
>15 (female)
Follicular 2-8 IU/L
Mid-Cycle 10-75 IU/L
Luteal 2-8 IU/L
Post-Menopausal >15 IU/L
Antenatal <1 IU/L
Male 2-9 IU/L
Lipase 10-70 U/L
Magnesium 0.6-1.2 mmol/L
Oestradiol Follicular 77-920 pmol/L
Mid-Cycle 140-2380 pmol/L
Luteal 77-1145 pmol/L
Post-Menopausal <103 pmol/L
Male <160 pmol/L
Osmolality 280-300 mosm/kg
Phosphate <30 days 1.3-2.5 mmol/L
30 days - 1 yr 1.2-2.2 mmol/L
>1-4 yrs 1.1-2.0 mmol/L
>4-11 yrs 1.0-2.0 mmol/L
>11-16 yrs 0.9-1.9 mmol/L
>16 yrs 0.8-1.5 mmol/L
Potassium 3.5-5.2 mmol/L
Progesterone Follicular 1-4 nmol/L
Luteal 15-100 nmol/L
Post-Menopausal <4 nmol/L
Male 0-1 nmol/L
Prolactin Female 25-630 mIU/L
Male 55-380 mIU/L
Protein (Total) <2 months 45/70 g/L
>2-12 months 50-80 g/L
>1-6 yrs 55/80 g/L
>6-11 yrs 60-83 g/L
>11 yrs 64-83 g/L
PSA <4.0 ug/L
PTH (Intact) 1.6-7.2 pmol/L
Rheumatoid Factor <30 IU/L
Sodium 135-145 mmol/L
Transferrin <2 months 1.3-2.3 g/L
>2 months - 3 yrs 1.6-3.3 g/L
>3 yrs 2.0-3.5 g/L
% Saturation Male 20-60 %
Female 20-50 %
hs-Troponin I Male 0-34 ng/L
Female 0-16 ng/L
TSH <4 days 1.0-20.0 mIU/L
4 days - 1 month 0.7-16.0 mIU/L
>1-6 months 0.5-6.0 mIU/L
>6 months 0.4-4.0 mIU/L
Free T4 4 days - <1 month 10-40 pmol/L
1 month - <1 yr 10-30 pmol/L
1-<12 yrs 11-22 pmol/L
12 yrs and above 12-22 pmol/L
Free T3 <12 months 4.5-10.5 pmol/L
1-12 yrs 3.8-8.6 pmol/L
>12-18 yrs 3.7-7.7 pmol/L
>18 yrs 2.5-6.0 pmol/L
Urea <1 month 1.1-6.1 mmol/L
>1 month - 2 yrs 0.7-5.0 mmol/L
>2-4 yrs 1.1-5.0 mmol/L
>4-6 yrs 1.1-5.7 mmol/L
>6-10 yrs 1.4-5.7 mmol/L
>10-13 yrs 1.8-6.4 mmol/L
>13 yrs 3.2-7.7 mmol/L
Uric Acid 0-12 yrs 0.08-0.34 mmol/L
>12 yrs (male) 0.20-0.42 mmol/L
>12 yrs (female) 0.15-0.36 mmol/L


BLODD GASES ARTERIAL VENOUS UNITS COMMENTS
pH 7.35-7.45 7.30-7.40
pCO2 35-45 40-50 mmHg
pO2 75-105 mmHg
Bicarbonate (HCO3) 22-28 22-32 mmol/L
Standard Bicarbonate 22-28 22-32 mmol/L
Base Excess (ABE) +/- 3 +/- 3 mmol/L
o2 Saturation 97-100 %
Carboxyhaemoglobin (COHb) 0-1.5 (non-smoker) 0-1.5 (non-smoker) %
<9 (smoker) <9 (smoker) %
MetHb 0-1.5 0-1.5 %
Sodium 135-145 135-145 mmol/L
Potassium 3.5-5.2 3.5-5.2 mmol/L
Ionised Calcium 1.15-1.30 1.15-1.30 mmol/L
Ionised Calcium - corrected (pH 7.4) 1.13-1.26 1.13-1.26 mmol/L
Chloride 95-110 95-110 mmol/L
Glucose (random) 3.5-7.7 3.5-7.7 mmol/L
Lactate <2.0 <2.0 mmol/L
Anion Gap 10-20 10-20 mmol/L
CORD GASES ARTERIAL VENOUS UNITS COMMENTS
pH 7.10-7.40 7.22-7.44
pCO2 42-74 28-53 mmHg
pO2 6-28 16-40 mmHg
HCO3 18-28 17-26 mmol/L
Base Excess -12 to +2 -12 to +2 mmol/L
Lactate <6.1 <6.1 mmol/L


Urine SEX/AGE REF RANGE UNITS COMMENTS
U Calcium (24hrs) 2.5-7.5 mmol/24hrs
U Creatinine (24hrs) 0-6 months 0.2-1.6 mmol/24hrs
>6 months - 2 yrs 0.2-2.0 mmol/24hrs
>2-6 yrs 0.5-6.0 mmol/24hrs
>6-10 yrs 1.5-12.6 mmol/24hrs
>10-15 yrs 2.0-20.0 mmol/24hrs
>15 yrs (male) 9.0-18.0 mmol/24hrs
>15 yrs (female) 7.0-12.5 mmol/24hrs
Creatinine Clearance >1.5 ml/sec
U Albumin <30 mg/L
U Alb/Crn Ratio Male <2.5 g(alb)/mol(Crn)
Female <3.5 g(alb)/mol(Crn)
U Osmolality 0-6 yrs 50-1200 mosm/kg
>6 yrs 300-1200 mosm/kg
U pH 5-8.8
U Phosphate (24hrs) 16-48 mmol/24hrs dependent on diet, age, muscle mass
U Potassium (24hrs) 35-100 mmol/24hrs diet dependent
U Protein (24hrs) 0.0-0.14 g/24hrs
U Pro/Crn Ratio <22.7 g/mol
U Sodium (24hrs) 100-250 mmol/24hrs diet dependent
U Urea (24hrs) 165-580 mmol/24hrs


LIPIDS SEX/AGE REF RANGE UNITS COMMENTS
Cholesterol (Total) <4.0 mmol/L
HDL Cholesterol >1.0 mmol/L
LDL (calculated) <2.5 mmol/L
Chol/HDL Ratio <4.5
Triglyceride <1.7 mmol/L

Optimal lipid levels are suggested by the New Zealand Guidelines Group. http://www.health.govt.nz/publication/new-zealand-primary-care-handbook-2012


DRUGS REF RANGE UNITS COMMENTS
Carbamazepine Therapeutic range 16-50 umol/L
Digoxin Therapeutic range 0.6-2.0 nmol/L >6 hrs post-dose
Ethanol Nil detected <2.2 mmol/L
Lithium for prophylaxis 0.4-0.8 mmol/L
for acute mania 0.8-1.2 mmol/L
toxicity is common >1.2 mmol/L >12 hrs post-dose
Phenytoin Therapeutic range 40-80 umol/L
Salicylate Therapeutic range 1.5-1.8 mmol/L
Toxic >3.6 mmol/L
Theophylline Therapeutic range 55-110 umol/L
Valproate <6 months 28-55 umol/L
>6 months 350-700 umol/L not reported but widely accepted as a trough range

Note: Antibiotics - Gentamicin, Vancomycin and Tobramycin ranges, please refer to Pharmacy for dose and time related reference ranges.


Reference ranges have been set in agreeance with: - The South Island Quality Assurance Group (SIQAG) - Chemical Pathology Network New Zealand (CHEMPNNZ) - Te Whatu Ora Hawkes Bay Chemical Pathologist - Abbott Alinity assay specific reference ranges - The LabNet Delphic Partners


Reference ranges reviewed August 2023

Retrieved from "https://hawkesbaylabmanual.co.nz/wiki/index.php?title=Biochemistry_Reference_Ranges&oldid=1280"